---
figid: PMC8517843__gr3
figtitle: ADAMs family in kidney physiology and pathology
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Abelmoschus manihot
organisms_ner:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Drosophila melanogaster
- Danio rerio
pmcid: PMC8517843
filename: gr3.jpg
figlink: /pmc/articles/PMC8517843/figure/fig0003/
number: F3
caption: Pathways of ADAM17 in the regulation of tubular epithelial cells, mesangial
  cells and podocytes. In response to kidney injury, ADAM17 activates the epidermal
  growth factor receptor pathway by inducing the MEK/ERK signaling, the JAK/STAT signaling
  and the NFκB signaling, which induces proinflammatory factors upregulation, inflammatory
  cell infiltration, and profibrotic factors release. The increased ADAM17-mediated
  ACE2 shedding exacerbates the imbalance of RAS, which increases inflammation and
  fibrosis in a looping feedback manner. And ADAM17 is involved in shedding membrane-bound
  IL-6 receptor and activating the IL-6 trans-signaling, which mediates renal inflammation
  and fibrosis by inducing the MAPK/ERK signaling, the JAK/STAT signaling, and the
  PI3K/AKT1 signaling. Moreover, ADAM17 mediates the release of CXCL16, which induces
  T cells and macrophages infiltration. In addition, the shedding of NADPH oxidase
  4 (Nox4) mediating ROS upregulation and matrix accumulation known to be implicated
  by ADAM17.
papertitle: ADAMs family in kidney physiology and pathology.
reftext: Huanhuan Zhu, et al. EBioMedicine. 2021 Oct;72:103628.
year: '2021'
doi: 10.1016/j.ebiom.2021.103628
journal_title: EBioMedicine
journal_nlm_ta: EBioMedicine
publisher_name: Elsevier
keywords: A disintegrin and metalloproteinases | Nephrogenesis | Inflammation | Fibrosis
automl_pathway: 0.9544402
figid_alias: PMC8517843__F3
figtype: Figure
redirect_from: /figures/PMC8517843__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8517843__gr3.html
  '@type': Dataset
  description: Pathways of ADAM17 in the regulation of tubular epithelial cells, mesangial
    cells and podocytes. In response to kidney injury, ADAM17 activates the epidermal
    growth factor receptor pathway by inducing the MEK/ERK signaling, the JAK/STAT
    signaling and the NFκB signaling, which induces proinflammatory factors upregulation,
    inflammatory cell infiltration, and profibrotic factors release. The increased
    ADAM17-mediated ACE2 shedding exacerbates the imbalance of RAS, which increases
    inflammation and fibrosis in a looping feedback manner. And ADAM17 is involved
    in shedding membrane-bound IL-6 receptor and activating the IL-6 trans-signaling,
    which mediates renal inflammation and fibrosis by inducing the MAPK/ERK signaling,
    the JAK/STAT signaling, and the PI3K/AKT1 signaling. Moreover, ADAM17 mediates
    the release of CXCL16, which induces T cells and macrophages infiltration. In
    addition, the shedding of NADPH oxidase 4 (Nox4) mediating ROS upregulation and
    matrix accumulation known to be implicated by ADAM17.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Mdk
  - Ephb2
  - Mapk1
  - Egfr
  - Itk
  - Slc22a3
  - Cxcl16
  - Ang3
  - Angpt4
  - Angptl1
  - Angpt1
  - Ang
  - Tm7sf2
  - Ang2
  - Angpt2
  - Ang4
  - Ang5
  - Ang6
  - Agt
  - Ace2
  - Nox4
  - Il6ra
  - Pik3r1
  - Ephb1
  - Il6r
  - Pik3cg
  - COL6A1
  - COL6A2
  - COL6A3
  - COL6A5
  - COL6A6
  - COL7A1
  - COL8A1
  - COL8A2
  - COL9A1
  - COL9A2
  - COL9A3
  - COL10A1
  - COL11A1
  - COL11A2
  - COL12A1
  - COL13A1
  - COL14A1
  - COL15A1
  - COL16A1
  - COL17A1
  - COL18A1
  - COL19A1
  - COL20A1
  - COL21A1
  - COL22A1
  - COL23A1
  - COL24A1
  - COL25A1
  - COL26A1
  - COL27A1
  - COL28A1
  - COL1A1
  - COL1A2
  - COL4A1
  - COL4A2
  - COL4A3
  - COL4A4
  - COL4A5
  - COL4A6
  - COL5A1
  - COL5A2
  - COL5A3
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - MAPK1
  - MAPK3
  - EGFR
  - SOAT1
  - STAT1
  - STAT2
  - STAT3
  - STAT4
  - STAT6
  - STAT5A
  - STAT5B
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - ITK
  - SLC22A3
  - CXCL16
  - MAS1
  - VPS51
  - ANGPTL1
  - ANGPT4
  - ANGPT1
  - TM7SF2
  - ANGPT2
  - ANGPTL3
  - ACE2
  - NOX4
  - IL6R
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - op
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - Dsor1
  - Mtk
  - Erk7
  - rl
  - Stat92E
  - hop
  - bsk
  - mas
  - myoblast-specific
  - Ace
  - Nox
  - MKP-4
  - p38b
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - egfra
  - stat1b
  - stat4
  - angpt1
  - angpt2b
  - ace2
  - nox4
  - il6r
---
